EMAIL THIS PAGE TO A FRIEND

Biochimica et biophysica acta

Proteomics profiling of cholangiocarcinoma exosomes: A potential role of oncogenic protein transferring in cancer progression.


PMID 26148937

Abstract

Cholangiocarcinoma (CCA), a common primary malignant tumor of bile duct epithelia, is highly prevalent in Asian countries and unresponsive to chemotherapeutic drugs. Thus, a newly recognized biological entity for early diagnosis and treatment is highly needed. Exosomes are small membrane bound vesicles found in body fluids and released by most cell types including cancer cells. The vesicles contain specific subset of proteins and nucleic acids corresponding to cell types and play essential roles in pathophysiological processes. The present study aimed to assess the protein profiles of CCA-derived exosomes and their potential roles. We have isolated exosomes from CCA cells namely KKU-M213 and KKU-100 derived from Thai patients and their roles were investigated by incubation with normal human cholangiocyte (H69) cells. Exosomes were internalized into H69 cells and had no effects on viability or proliferation of the host cells. Interestingly, the exosomes from KKU-M213 cells only induced migration and invasion of H69 cells. Proteomic analysis of the exosomes from KKU-M213 cells disclosed multiple cancer related proteins that are not present in H69 exosomes. Consistent with the protein profile, treatment with KKU-M213 exosomes induced β-catenin and reduced E-cadherin expressions in H69 cells. Collectively, our results suggest that a direct cell-to-cell transfer of oncogenic proteins via exosomal pathway may be a novel mechanism for CCA progression and metastasis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA007234
Anti-CD81 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB3500454
Anti-CD81 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701919 Anti-flot1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA001393
Anti-FLOT1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410072
Anti-FLOT1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2500404
Anti-Flotillin 1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F1180
Anti-Flotillin 1 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
AV38773
Anti-TSG101 (AB1) antibody produced in rabbit, IgG fraction of antiserum
AV37310
Anti-TSG101 (AB2) antibody produced in rabbit, IgG fraction of antiserum
AV37911
Anti-TSG101 (AB3) antibody produced in rabbit, IgG fraction of antiserum
T5951
Anti-TSG101 (C-terminal) antibody produced in rabbit, ~1.5 mg/mL, affinity isolated antibody, buffered aqueous solution
T5826
Anti-TSG101 (N-terminal) antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB1406556
Anti-TSG101 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
T5701
Anti-TSG101 antibody produced in rabbit, ~2 mg/mL, affinity isolated antibody, buffered aqueous solution
HPA006161
Anti-TSG101 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0000975M1
Monoclonal Anti-CD81 antibody produced in mouse, clone 2B7, purified immunoglobulin, buffered aqueous solution
SAB4700232 Monoclonal Anti-CD81 antibody produced in mouse, clone M38, purified immunoglobulin, buffered aqueous solution
SAB1403056
Monoclonal Anti-FLOT1 antibody produced in mouse, clone 4A1, ascites fluid
WH0007251M1
Monoclonal Anti-TSG101 antibody produced in mouse, clone 5B7, purified immunoglobulin, buffered aqueous solution
SAB2702167
Monoclonal Anti-TSG101 antibody produced in mouse
PLA0283
Rabbit anti-TSG101 Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.